Ostarine, a selective androgen receptor modulator (SARM) first developed by University of Tennessee researcher James Dalton in the early 2000s, has repeatedly turned up in athletes’ drug tests and is still disrupting sports, the New York Times reports (Feb. 2, 2026). The drug’s presence has affected competitors across disciplines